Our non-profit and family partners are an active part in achieving our goals to advance pediatric cancer therapies through ground-breaking new trials.
Artisan Biopharma
Introducing Artisan Biopharma
Artisan Biopharma is a for-profit public benefit corporation owned entirely by the Children’s Cancer Therapy Development Institute (cc-TDI). We are the connection for moving breakthrough research and development at cc-TDI into transformative clinical trials. Our mission is to provide research-driven interventions for the treatment and prevention of cancer in children.
Artisan Advantage
As a subsidiary of cc-TDI, we are well-positioned to rapidly move new or existing drugs with pediatric disease indications to clinical trials, while de-risking capital investment. We are leading with deep preclinical knowledge from cc-TDI’s drug discovery engine and have an extensive pipeline of drug candidates ready to pursue clinical development. Similarly, we aim to use existing, shelved drugs for new pediatric indications using our extensive research in the pediatric cancer research space. We also have pre-existing relationships with academic and industry partners. And most importantly, we are launching Artisan with a support network of 3000+ families touched by pediatric cancer from around the world.
Our team at Artisan recognizes that to make a lasting change, you need the strength of a community. We seek to form a consortium of research centers, pharmaceutical leaders, nonprofit foundations, investors and families to disrupt the current system.
Pharma & Labs
Artisan Biopharma is not solely committed to developing treatments, but we are working to identify promising targeted therapeutics that already exist with pharmaceutical and lab partners.
